The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia-Reference-Cited by-同舟云学术

The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia

Published:2000-07 Issue:11 Volume:36 Page:1395-1401
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Perego R.A,Costantini M,Cornacchini G,Gargantini L,Bianchi C,Pungolino E,Rovida E,Morra E

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr–abl fused gene;Shtivelman;Cell,1986

2. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature;Mills;Blood,1991

3. Relationship of the type of bcr-abl hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia;Futaki;Leukemia Res.,1992

4. The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia;Zaccaria;Br. J. Haematol.,1993

5. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia;Rozman;Leukemia,1995

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis;Genes;2024-02-12

2. Does platelet aggregation differ among chronic myeloid leukemia-chronic phase (CML-CP) patients on tyrosine kinase inhibitors (TKIs)? A tertiary center experience;The Egyptian Journal of Haematology;2023-04

3. Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing;Life;2021-10-30

4. Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?;Cancers;2021-08-19

5. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib;Journal of Clinical Medicine;2021-07-16